Pharmaceutical know-how

Technical and financial assessment of intangible assets.

Need

This company from the Friuli area, which is listed on the 'AIM Italia' market and reports a turnover of €16 million, operates in the B2B chemical and pharmaceuticals industry, concentrating on the research, development, and production of original and generic pharmaceutical products for human and veterinary use. The company - which has several patents to its name and a wealth of internal technical and technology Know-How linked to pharmaceutical dossiers - set out a need for a technical and financial assessment of its assets.

Solution

WIL was involved in several areas:

• collection and analysis of quality-related, accounting, and technical information, as well as business planning;
  
• examination of the company's intangible assets and the legal protection measures in place, in addition to identification and assessment of the core technical and financial parameters;
  
• evaluation and selection of the assessment methodology through analysis of the main technical and financial factors and the factors which prevent assessment of the intangible assets in question;
  
• preparation of a technical/financial assessment report on the company's intangible assets, accompanied by appendixes and documents to help understand and verify the results obtained.
  

Benefits

Use of the assessment for support in the event of exceptional corporate transactions.